Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome

Overview

Journal J Neurosci

Specialty Neurology

Date 2021 Dec 2

PMID 34853083

Citations 8

Authors

Ronald McGregor

Ming-Fung Wu

Brent Holmes

Hoa Anh Lam

Nigel T Maidment

Joseph Gera

Akihiro Yamanaka

Jerome M Siegel

Affiliations

Soon will be listed here.

Abstract

We previously found that human heroin addicts and mice chronically exposed to morphine exhibit a significant increase in the number of detected hypocretin/orexin (Hcrt)-producing neurons. However, it remains unknown how this increase affects target areas of the hypocretin system involved in opioid withdrawal, including norepinephrine containing structures locus coeruleus (LC) and A1/A2 medullary regions. Using a combination of immunohistochemical, biochemical, imaging, and behavioral techniques, we now show that the increase in detected hypocretin cell number translates into a significant increase in hypocretin innervation and tyrosine hydroxylase (TH) levels in the LC without affecting norepinephrine-containing neuronal cell number. We show that the increase in TH is completely dependent on Hcrt innervation. The A1/A2 regions were unaffected by morphine treatment. Manipulation of the Hcrt system may affect opioid addiction and withdrawal. Previously, we have shown that the hypothalamic hypocretin system undergoes profound anatomic changes in human heroin addicts and in mice exposed to morphine, suggesting a role of this system in the development of addictive behaviors. The locus coeruleus plays a key role in opioid addiction. Here we report that the hypothalamic hypocretin innervation of the locus coeruleus increases dramatically with morphine administration to mice. This increase is correlated with a massive increase in tyrosine hydroxylase expression in locus coeruleus. Elimination of hypocretin neurons prevents the tyrosine hydroxylase increase in locus coeruleus and dampens the somatic and affective components of opioid withdrawal.

Citing Articles

Opioid-induced neuroanatomical, microglial and behavioral changes are blocked by suvorexant without diminishing opioid analgesia.

McGregor R, Wu M, Thannickal T, Li S, Siegel J Nat Ment Health. 2025; 2(9):1018-1031.

PMID: 39989723 PMC: 11845277. DOI: 10.1038/s44220-024-00278-2.

Suvorexant enhances oxycodone-induced respiratory depression in male rats.

Moreira-Junior E, Rowlett J, Berro L Drug Alcohol Depend. 2024; 264:112434.

PMID: 39255740 PMC: 11527583. DOI: 10.1016/j.drugalcdep.2024.112434.

AKAP150 from nucleus accumbens dopamine D1 and D2 receptor-expressing medium spiny neurons regulates morphine withdrawal.

Bai X, Zhang K, Ou C, Mu Y, Chi D, Zhang J iScience. 2023; 26(11):108227.

PMID: 37953959 PMC: 10637943. DOI: 10.1016/j.isci.2023.108227.

Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain.

Ruggiero E, Pambuku A, Caccese M, Lombardi G, Gallio I, Brunello A Front Pain Res (Lausanne). 2023; 4:1256809.

PMID: 37810433 PMC: 10556467. DOI: 10.3389/fpain.2023.1256809.

Biological sex influences sleep phenotype in mice experiencing spontaneous opioid withdrawal.

Tisdale R, Sun Y, Park S, Ma S, Haire M, Allocca G J Sleep Res. 2023; 33(3):e14037.

PMID: 37731248 PMC: 10950840. DOI: 10.1111/jsr.14037.

References

Blanco-Centurion C, Gerashchenko D, Shiromani P . Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci. 2007; 27(51):14041-8. PMC: 2975593. DOI: 10.1523/JNEUROSCI.3217-07.2007. View

Valentino R, Van Bockstaele E . Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol. 2008; 583(2-3):194-203. PMC: 2349983. DOI: 10.1016/j.ejphar.2007.11.062. View

Kaeidi A, Azizi H, Javan M, Ahmadi Soleimani S, Fathollahi Y, Semnanian S . Direct Facilitatory Role of Paragigantocellularis Neurons in Opiate Withdrawal-Induced Hyperactivity of Rat Locus Coeruleus Neurons: An In Vitro Study. PLoS One. 2015; 10(7):e0134873. PMC: 4521852. DOI: 10.1371/journal.pone.0134873. View

Dauvilliers Y, Lopez R, Ohayon M, Bayard S . Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med. 2013; 11:78. PMC: 3621400. DOI: 10.1186/1741-7015-11-78. View

Puskas N, Papp R, Gallatz K, Palkovits M . Interactions between orexin-immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice. Peptides. 2010; 31(8):1589-97. DOI: 10.1016/j.peptides.2010.04.020. View

Jalal H, Buchanich J, Roberts M, Balmert L, Zhang K, Burke D . Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018; 361(6408). PMC: 8025225. DOI: 10.1126/science.aau1184. View

Zhang Q, Liu Q, Li T, Liu Y, Wang L, Zhang Z . Expression and colocalization of NMDA receptor and FosB/ΔFosB in sensitive brain regions in rats after chronic morphine exposure. Neurosci Lett. 2015; 614:70-6. DOI: 10.1016/j.neulet.2015.11.052. View

Kobayashi K, Nagatsu T . Molecular genetics of tyrosine 3-monooxygenase and inherited diseases. Biochem Biophys Res Commun. 2005; 338(1):267-70. DOI: 10.1016/j.bbrc.2005.07.186. View

Mazei-Robison M, Nestler E . Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons. Cold Spring Harb Perspect Med. 2012; 2(7):a012070. PMC: 3385942. DOI: 10.1101/cshperspect.a012070. View

10.

Tabuchi S, Tsunematsu T, Black S, Tominaga M, Maruyama M, Takagi K . Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function. J Neurosci. 2014; 34(19):6495-509. PMC: 4012309. DOI: 10.1523/JNEUROSCI.0073-14.2014. View

11.

Darke S, Kaye S, Duflou J, Lappin J . Completed Suicide Among Methamphetamine Users: A National Study. Suicide Life Threat Behav. 2018; 49(1):328-337. DOI: 10.1111/sltb.12442. View

12.

Brown M, Guilleminault C . A review of sodium oxybate and baclofen in the treatment of sleep disorders. Curr Pharm Des. 2011; 17(15):1430-5. DOI: 10.2174/138161211796197098. View

13.

Harris G, Wimmer M, Aston-Jones G . A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005; 437(7058):556-9. DOI: 10.1038/nature04071. View

14.

Nestler E, Barrot M, DiLeone R, Eisch A, Gold S, Monteggia L . Neurobiology of depression. Neuron. 2002; 34(1):13-25. DOI: 10.1016/s0896-6273(02)00653-0. View

15.

Jaremko K, Thompson Jr N, Reyes B, Jin J, Ebersole B, Jenney C . Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 50:53-65. PMC: 3928604. DOI: 10.1016/j.pnpbp.2013.12.003. View

16.

Delfs J, Zhu Y, Druhan J, Aston-Jones G . Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature. 2000; 403(6768):430-4. DOI: 10.1038/35000212. View

17.

Chaijale N, Curtis A, Wood S, Zhang X, Bhatnagar S, Reyes B . Social stress engages opioid regulation of locus coeruleus norepinephrine neurons and induces a state of cellular and physical opiate dependence. Neuropsychopharmacology. 2013; 38(10):1833-43. PMC: 3746692. DOI: 10.1038/npp.2013.117. View

18.

Laorden M, Ferenczi S, Pinter-Kubler B, Gonzalez-Martin L, Lasheras M, Kovacs K . Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One. 2012; 7(5):e36871. PMC: 3348891. DOI: 10.1371/journal.pone.0036871. View

19.

Thannickal T, Moore R, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M . Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000; 27(3):469-74. PMC: 8760623. DOI: 10.1016/s0896-6273(00)00058-1. View

20.

Turner C, Chandrakumar D, Rowe C, Santos G, Riley E, Coffin P . Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015. Drug Alcohol Depend. 2018; 185:305-312. PMC: 6474784. DOI: 10.1016/j.drugalcdep.2017.12.030. View